A binding international convention would facilitate a move towards more equitable access to R&D in health, according to Suerie Moon and colleagues.

An editorial in the journal Nature explains the reasons for publishing the full results of a controversial paper about a modified bird flu virus

Emerging resistance to artemisinin means efforts to track genetic markers and regulate the drug's use must step up, says Priya Shetty.

Trade deals are threatening generic drugs — we need new ways to incentivise affordable drug development, says health expert Daniele Dionisio.

India urgently needs a permanent dengue surveillance system, say N. Sivagnaname and colleagues.

There is a pressing need for Africa to bolster its pharmaceuticals industry, and that requires the right policy framework, argues Priya Shetty.

Improving health for the poor depends on nurturing local innovations — and learning how to deliver them, argue Abdallah Daar and Peter Singer.

Africa needs to up its game in malaria research, but by doing what it does best, not by replicating Western research, says Linda Nordling.

The revised malaria death toll suggests a need for research into uncertainties in controlling neglected tropical diseases, says Mark Booth.

India's carefully targeted strategy against polio holds lessons for other countries, and for other diseases, argues Priya Shetty.

Encouraging demand for new and increasingly cheap interventions available now can boost health in developing countries, says Charles Kenny.

Neither dispassionate information nor scare stories are the answer: we need public engagement on health interventions, argues Priya Shetty.

Much progress has been made in genomics research, says Stephen Baker, but the impact on public health is limited in the developing world.

Healthcare policies and research strategies in developing countries must adapt to the new big killers, says Priya Shetty.

Commercial antibody blood tests for TB have been declared ineffective by the WHO, but it is up to governments to halt their use, writes epidemiologist and TB researcher Madhukar Pai.

Excitement about new drug treatment for HIV prevention does not mean we should lose sight of other methods, cautions Priya Shetty.

Reproductive and sexual health programmes in the developing world are more effective if they engage both sexes, says Priya Shetty.

Three key approaches could reduce the number of cholera cases and prevent diseases of poverty in Haiti, say experts in PLoS NTDS.

Vaccination campaigns to eradicate polio must change how they engage with local communities, say Heidi J. Larson and Isaac Ghinai.

Few causes are more worthy of funding than vaccines, says Priya Shetty, and the developing world relies on GAVI getting the billions it needs.